内皮Nox2通过调控TLR4表达限制内毒素血症中的全身炎症和低血压
该研究在小鼠内毒素血症模型中探究内皮细胞Nox2的作用。采用Tie2靶向Nox2缺失或转基因过表达小鼠,以及骨髓嵌合体区分白细胞与内皮细胞Nox2。结果显示,Tie2靶向Nox2缺失加重LPS诱导的TNF-α升高、肺中性粒细胞扣押和低血压,而Tie2驱动Nox2过表达减轻炎症并预防低血压。内皮Nox2通过控制NF-κB活化和TLR4转录发挥作用。
要点
- Tie2靶向Nox2缺失小鼠在LPS注射后循环TNF-α升高、肺中性粒细胞扣押增多、低血压加重,提示内皮Nox2具有保护作用。
- Tie2驱动Nox2过表达可减轻LPS诱导的炎症并预防低血压。
- 骨髓嵌合体实验显示,白细胞或内皮细胞Nox2缺失均降低LPS诱导的肺中性粒细胞扣押和血浆TNF-α水平。
- 显著的低血压反应仅见于内皮特异性Nox2缺失小鼠,提示内皮Nox2对血压调控具有独特作用。
- 体外实验(HUVEC和HAEC)显示内皮Nox2控制NF-κB活化和TLR4转录。
适用人群与场景
- LPS诱导的内毒素血症小鼠模型;体外实验使用人脐静脉内皮细胞(HUVEC)和人主动脉内皮细胞(HAEC)。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:动物实验(小鼠)及体外细胞实验;样本量与中心数原文未提及。干预:静脉注射LPS于Tie2靶向Nox2缺失或转基因过表达小鼠,并构建骨髓嵌合体区分白细胞与内皮细胞Nox2。主要结果:Tie2靶向Nox2缺失小鼠LPS注射后循环TNF-α升高、肺中性粒细胞扣押增多、低血压加重;Tie2驱动Nox2过表达减轻炎症并预防低血压;白细胞或内皮细胞Nox2缺失均减少肺中性粒细胞扣押和血浆TNF-α,但显著低血压仅见于内皮特异性Nox2缺失
证据类型、等级与局限
- 证据类型:动物实验(小鼠)及体外细胞实验;证据等级或推荐强度原文未提及;局限:原文未提及,设计本身为临床前研究,结果不能直接外推至人类。
对床旁实践的改变
- 原文未提及
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Leukocyte Nox2 is recognized to have a fundamental microbicidal function in sepsis but the specific role of Nox2 in endothelial cells (EC) remains poorly elucidated. Here, we tested the hypothesis that endothelial Nox2 participates in the pathogenesis of systemic inflammation and hypotension induced by LPS. LPS was injected intravenously in mice with Tie2-targeted deficiency or transgenic overexpression of Nox2. Mice with Tie2-targeted Nox2 deficiency had increased circulating levels of TNF-α, enhanced numbers of neutrophils trapped in lungs, and aggravated hypotension after LPS injection, as compared to control LPS-injected animals. In contrast, Tie2-driven Nox2 overexpression attenuated inflammation and prevented the hypotension induced by LPS. Because Tie2-Cre targets both EC and myeloid cells we generated bone marrow chimeric mice with Nox2 deletion restricted to leukocytes or ECs. Mice deficient in Nox2 either in leukocytes or ECs had reduced LPS-induced neutrophil trapping in the lungs and lower plasma TNF-α levels as compared to control LPS-injected mice. However, the pronounced hypotensive response to LPS was present only in mice with EC-specific Nox2 deletion. Experiments in vitro with human vein or aortic endothelial cells (HUVEC and HAEC, respectively) treated with LPS revealed that EC Nox2 controls NF-κB activation and the transcription of toll-like receptor 4 (TLR4), which is the recognition receptor for LPS. In conclusion, these results suggest that endothelial Nox2 limits NF-κB activation and TLR4 expression, which in turn attenuates the severity of hypotension and systemic inflammation induced by LPS.
参考来源
- Trevelin SC, Sag CM, Zhang M, et al. Endothelial Nox2 Limits Systemic Inflammation and Hypotension in Endotoxemia by Controlling Expression of Toll-Like Receptor 4. Shock. 2021. PMID: 34276040. doi:10.1097/SHK.0000000000001706
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。